Radovan Malý/X
Aug 4, 2026, 02:15
Radovan Malý: Finding the Optimal Aspirin Dose in Acute Coronary Syndrome
Radovan Malý, Head of Department at Charles Univeristy in Prague, shared a post on X about a recent article by John W. Eikelboom et al., published in Thrombosis Research, adding:
“Aspirin dose, urinary thromboxane and prostacyclin metabolites, and clinical outcome in acute coronary syndrome:
A nested case-control study from CURRENT-OASIS 7 – Thrombosis Research”
Title: Aspirin dose, urinary thromboxane and prostacyclin metabolites, and clinical outcome in acute coronary syndrome: A nested case-control study from CURRENT-OASIS 7
Authors: John W. Eikelboom, Shamir R. Mehta, Qilong Yi, Jeffrey I. Weitz
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 21, 2026, 03:00Family History Can Reveal Hidden Risk of Aortic Dissection – The Marfan Foundation
-
Sep 21, 2026, 02:47Transitioning from Paediatric to Adult Haemophilia Care – Haemophilia Foundation Australia
-
Sep 21, 2026, 02:29Diana Castro Paupério: A New Era for Patient Blood Management
-
Sep 21, 2026, 00:29Iheanyichukwu Ike: Childhood Anaemia in Nigeria Through an Analysis of the 2018 NDHS
-
Sep 21, 2026, 00:27Nicole De Vita: The Global Burden of Iron Deficiency and Anemia in Women at SABM
-
Sep 21, 2026, 00:25Giuseppe Panuccio: IVUS and OCT Guidance Reduce MACE and Stent Thrombosis in Calcified Coronary Lesions
-
Sep 21, 2026, 00:23Parveen Yograj: Anemia in Older Adults 2026 – Don’t Call It “Just Old Age” and Find the Cause
-
Sep 21, 2026, 00:22Peter A. McCullough: McCullough Protocol Base Spike Detoxification and Oral Anticoagulation for Athletes
-
Sep 21, 2026, 00:20Rolando Claure: Apixaban Shows a More Favorable Benefit Risk Balance in Advanced CKD With AF